DEVELOPMENT
HISTORY

VVN001 China Phase III trial FPI 

VVN539 US Phase II trial completed
VVN461 China Phase I trial completed
Round D2 capital fund raising completed, led by V-capital
Commercialization collaboration negotiation on-going 

VVN001 US Phase II trial completed
VVN001 China Phase II trial completed
VVN539 US Phase II trial FPI
VVN461 China Phase I trial IND

VVN001 China Phase I trial FPI
VVN001 China Phase II trial FPI
Round D capital fund raising completed, led by Sequoia Capital, followed by GTJA investment, Cenova Ventures

VVN001 US Phase II trial kick off

Round C capital fund raising completed, led by various leading VCs in China

Round B capital fund raising completed, led by VC Lapam Capital

Round A capital fund raising completed

VivaVision is a clinical stage biotech company established in Shanghai, China in 2016
Incubated by Viva Biotech